个人科研网厅 | | 帮助
高级检索
当前位置： 首页 > 详情页

Phase I trial of SHR-A1811 in HER2-expressing advanced gastric cancer (GC) or gastroesophageal junction adenocarcinoma (GEJ) and colorectal cancer (CRC)

| 导出 | |

文献详情

资源类型：
WOS体系：

收录情况： ◇ SCIE ◇ CPCI(ISTP)

作者：
Li, J.[1] * ; Luo, S.[2] ; Liu, T.[3] ; Dong, L.[4] ; Yuan, X.[5] ; Feng, J.[6] ; Wang, Y.[7] ; Deng, Y.[8] ; Chen, J.[9] ; Zhang, M.[10] ; Zhou, H.[11] ; Cao, Y.[12] ; Qiu, W.[13] ; Ren, X.[14] ; Cai, S.[15] ; Dong, Y.[16] ; Wang, W.[17] ; Shen, Y.[18] ; Dou, N.[18] ; Huang, C.[18] ;
单位： [1]Shanghai East Hosp, South Div, Dept Med Oncol, Shanghai, Peoples R China [2]Affiliated Canc Hosp Zhengzhou Univ & Henan Canc, Phase I Clin Res Ctr, Zhengzhou, Peoples R China [3]Fudan Univ, Zhongshan Hosp, Dept Med Oncol, Shanghai, Peoples R China [4]Huazhong Univ Sci & Technol,Tongji Hosp,Tongji Med Coll,Dept Pharm,Wuhan,Peoples R China [5]Huazhong Univ Sci & Technol,Tongji Hosp,Tongji Med Coll,Dept Digest Oncol,Wuhan,Peoples R China [6]Nanjing Med Univ Affiliated Canc Hosp, Jiangsu Canc Hosp, Jiangsu Inst Canc Res, Dept Med Oncol, Nanjing, Peoples R China [7]Chinese Acad Med Sci, Canc Hosp Affiliated Shanxi Med Univ, Shanxi Hosp Affiliated Canc Hosp, Shanxi Prov Canc Hosp,Dept Gastroenterol, Taiyuan, Peoples R China [8]Sun Yat Sen Univ, Affiliated Hosp 6, Dept Med Oncol, Guangzhou, Peoples R China [9]Nanchang Univ, Affiliated Hosp 1, Dept Oncol, Nanchang, Jiangxi, Peoples R China [10]Bengbu Med Coll, Affiliated Hosp 1, Dept Gastrointestinal Surg, Bengbu, Peoples R China [11]Bengbu Med Coll, Affiliated Hosp 1, Phase I Clin Trial Lab, Bengbu, Peoples R China [12]Affiliated Hosp Qingdao Univ, Phase I Clin Res Ctr, Qingdao, Peoples R China [13]Affiliated Hosp Qingdao Univ, Dept Oncol, Qingdao, Peoples R China [14]Tianjin Med Univ Canc Inst & Hosp, Dept Biotherapy, Tianjin, Peoples R China [15]Sun Yat Sen Univ, Affiliated Hosp 1, Dept Gastrointestinal Surg, Guangzhou, Guangdong, Peoples R China [16]Sun Yat Sen Univ, Affiliated Hosp 1, Dept Cardiol, Guangzhou, Guangdong, Peoples R China [17]Hunan Canc Hosp, Gastroenterol & Urol Dept 2, Changsha, Peoples R China [18]Jiangsu Hengrui Pharmaceut Co Ltd, Dept Clin Dev, Shanghai, Peoples R China
出处：
DOI： 10.1016/j.annonc.2023.09.1870
ISSN：
基金：
Jiangsu Hengrui Pharmaceuticals, Co., Ltd.
语种：
外文
WOS：
中科院(CAS)分区：
出版当年[2022]版：
大类 | 1 区 医学
小类 | 1 区 肿瘤学
最新[2025]版：
大类 | 1 区 医学
小类 | 1 区 肿瘤学
JCR分区：
出版当年[2021]版：
Q1 ONCOLOGY
最新[2023]版：
Q1 ONCOLOGY

影响因子： 最新[2023版] 最新五年平均 出版当年[2021版] 出版当年五年平均 出版前一年[2020版] 出版后一年[2022版]

第一作者：
第一作者单位： [1]Shanghai East Hosp, South Div, Dept Med Oncol, Shanghai, Peoples R China
推荐引用方式(GB/T 7714)：
Li J.,Luo S.,Liu T.,et al.Phase I trial of SHR-A1811 in HER2-expressing advanced gastric cancer (GC) or gastroesophageal junction adenocarcinoma (GEJ) and colorectal cancer (CRC)[J].ANNALS OF ONCOLOGY.2023,34:S478-S478.doi:10.1016/j.annonc.2023.09.1870.
APA：
Li, J.,Luo, S.,Liu, T.,Dong, L.,Yuan, X....&Huang, C..(2023).Phase I trial of SHR-A1811 in HER2-expressing advanced gastric cancer (GC) or gastroesophageal junction adenocarcinoma (GEJ) and colorectal cancer (CRC).ANNALS OF ONCOLOGY,34,
MLA：
Li, J.,et al."Phase I trial of SHR-A1811 in HER2-expressing advanced gastric cancer (GC) or gastroesophageal junction adenocarcinoma (GEJ) and colorectal cancer (CRC)".ANNALS OF ONCOLOGY 34.(2023):S478-S478

资源点击量：426 今日访问量：1 总访问量：409 更新日期：2025-04-01 建议使用谷歌、火狐浏览器 常见问题

版权所有：重庆聚合科技有限公司 渝ICP备12007440号-3 地址：重庆市两江新区泰山大道西段8号坤恩国际商务中心16层（401121）